Hospital Pharmacy - October 2020 - 322

322	
	17.	 Keast RS, Roper J. A Complex relationship among chemical
concentration, detection threshold, and suprathreshold intensity of bitter compounds. Chem Senses. 2007;32(3):245-253.
	18.	 Vikas A, Vandana K, Mahesh K, Vipin K, Pratim KC. Taste
assessment trials for sensory analysis of oral pharmaceutical
products. Pak J Pharm Sci. 2008;21(4):438-450.
	19.	 Salazar de Saavedra M, Saavedra Cuadra I. Application of a sensorial response model to the design of an oral liquid pharmaceutical dosage form. Drug Dev Ind Pharm. 2000;26(1):55-60.
	20.	 The United States Pharmacopeia, 31st rev, and The National
Formulary, 26th ed. Chapter <61> Microbiological Tests
- Microbiological Examination of Nonsterile Products:
Microbial Enumeration Tests. Rockville, MD: Presented at
The United States Pharmacopeial Convention; 2008.
	21.	Pawar S, Kumar A. Issues in the formulation of drugs for
oral use in children: role of excipients. Paediatr Drugs.
2002;4(6):371-379.
	22.	 Patel V, Desai T, Chavda B, et al. Extemporaneous dosage
form for oral liquids. Pharmacophore. 2011;2:86-103.
	23.	 Handbook of Pharmaceutical Excipients. 6th ed. Monographs
Carboxymethylcellulose Sodium. New Orleans, LA: American
Public Health Association; 2009.
	24.	 Handbook of Pharmaceutical Excipients. 6th ed. Monographs.
Sorbitol. New Orleans, LA: American Public Health Association;
2009.
	25.	 Handbook of Pharmaceutical Excipients. 6th ed. Monographs,
Saccharin Sodium. New Orleans, LA: American Public Health
Association; 2009.

Hospital Pharmacy 55(5)
	26.	 Jijo A, Flowerlet M. Taste masking of paediatric formulation:
a review on technologies, recent trends and regulatory aspects.
Int J Pharm Pharmsci. 2014;6(1):12-19.
	27.	 Lachman L, Liberman HA, Kanig JS. The Theory and Practice
of Industrial Pharmacy. 3rd ed. Bombay, India: Varghese
Publishing House; 1987:419-428.
	28.	 European Medicines Agency. Guideline on excipients in the
dossier for application for marketing authorization of a medicinal product. Doc. Ref. EMEA/CHMP/QWP/396951/2006.
London, England: European Medicines Agency, November
2006.
	29.	 Handbook of Pharmaceutical Excipients. 6th ed. Monographs,
Sodium Metabisulfite. New Orleans, LA: American Public
Health Association; 2009.
	30.	 Moghimipour E, Rezaee S, Salimi A, et al. Rheological behavior and stability of ciprofloxacin suspension: impact of structural vehicles and flocculating agent. J Adv Pharm Technol
Res. 2015;4(3):141-145.
	31.	 Flor S, Tripodi V, Scioscia S, et al. Fast and sensitive new
HPLC-UV method for determination of omeprazole and
major related substances in pharmaceutical formulation. J
Liqchromatogr Relat Technol. 2010;33:1666-1678.
32.	US Food & Drug Administration. Q2 (R1) validation of
	
-analytical procedures: text and methodology. Retrieved from
https://www.fda.gov/drugs/guidancecomplianceregulatoryin
formation/-
guidances/ucm265700.htm. Published March 22,
2018. Accessed April 12, 2019.
https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm265700.htm https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm265700.htm
Hospital Pharmacy - October 2020

Table of Contents for the Digital Edition of Hospital Pharmacy - October 2020
